We’re excited to announce that Prof. Dr. Alexander Steinkasserer, our Managing Partner and Co-founder, will present new data on behalf of the Universitätsklinikum Erlangen at the 2nd Barcelona Hair Meeting on September 13th.

Prof. Steinkasserer will present very recent findings regarding “Soluble CD83 as a Novel Therapeutic Approach for the Treatment of Alopecia”. The presentation will cover the striking effect of sCD83 on hair growth discovered in his lab and feature the newest insights on sCD83’s mode of action. This innovative research is the basis of our development at Mallia.

The current media spotlight on this indication and constantly growing interest illustrate the importance of exchanging knowledge and pushing forward scientific discoveries to help people affected by alopecia.

Find out more about the meeting here: barcelonahair.org and visit our website for more information about sCD83.